ANTAGONIST-MEDIATED DOWN-REGULATION OF 5-HYDROXYTRYPTAMINE TYPE-2 RECEPTOR GENE-EXPRESSION - MODULATION OF TRANSCRIPTION

Authors
Citation
M. Toth et T. Shenk, ANTAGONIST-MEDIATED DOWN-REGULATION OF 5-HYDROXYTRYPTAMINE TYPE-2 RECEPTOR GENE-EXPRESSION - MODULATION OF TRANSCRIPTION, Molecular pharmacology, 45(6), 1994, pp. 1095-1100
Citations number
31
Categorie Soggetti
Pharmacology & Pharmacy",Biology
Journal title
ISSN journal
0026895X
Volume
45
Issue
6
Year of publication
1994
Pages
1095 - 1100
Database
ISI
SICI code
0026-895X(1994)45:6<1095:ADO5TR>2.0.ZU;2-6
Abstract
Prolonged exposure to an agonist results in a progressive loss of most G protein-coupled receptors, whereas exposure to an antagonist causes increased receptor response. The 5-hydroxy-tryptamine (5-HT)(2) recep tor is down-regulated by agonists but, paradoxically, antagonists can also elicit a decrease in receptor density. Here we show that long ter m treatment with serotonin or mianserin, an antagonist and antidepress ant, results in reduced levels of both the 5-HT2 receptor and its RNA. Antagonist-induced down-regulation requires the presence of the 5-HT2 receptor, it occurs at the level of transcription, and it is mediated by a drug response sequence in the 5' flanking region of the 5-HT2 re ceptor gene. The effect of mianserin might result, at least in part, f rom its ability to modulate transcription.